Metabolic Syndrome and Nephrolithiasis Risk: Should the Medical Management of Nephrolithiasis Include the Treatment of Metabolic Syndrome?
John Michael DiBianco, MD, T.W. Jarrett, MD, Patrick Mufarrij, MD
This article reviews the relationship between metabolic syndrome and nephrolithiasis, as well as the clinical implications for patients with this dual diagnosis.
Conservative Management of Urinary Incontinence in Women
Izak Faiena, MD, Neal Patel, MD, Jaspreet S. Parihar, MD, Marc Calabrese, BA, Hari Tunuguntla, MD
Urinary incontinence in women has a high prevalence and causes significant morbidity. Given that urinary incontinence is not generally a progressive disease, conservative therapies play an integral part in the management of these patients. The authors conducted a nonsystematic review of the literature to identify high-quality studies that evaluated the different components of conservative management of stress urinary incontinence, including behavioral therapy, bladder training, pelvic floor muscle training, lifestyle changes, mechanical devices, vaginal cones, and electrical stimulation.
The Role of Minimally Invasive Surgical Techniques in the Management of Large-gland Benign Prostatic Hypertrophy
Ganesh Sivarajan, MD, Michael S. Borofsky, MD, Ojas Shah, MD, James E. Lingeman, MD, Herbert Lepor, MD
The authors present a comprehensive, evidence-based review of the efficacy and safety profile of modern minimally invasive treatments for large-gland benign prostatic hypertrophy.
Current Status of Hemostatic Agents and Sealants in Urologic Surgical Practice
Sashi S. Kommu, BSc(Hons), MBBS, Robert McArthur, BA(Hons), PGCE, Amr M. Emara MBBS, Utsav D. Reddy, MBBS, Christopher J. Anderson, MBChB, Neil J. Barber, BSc, MBBS, Raj A. Persad, MBBS, Christopher G. Eden, MBBS, MS
There has been a recent and near exponential increase in the use of hemostatic agents and sealants to supplement the rapidly evolving methods in the surgical management of urologic patients. This article reviews the use of hemostatic agents and sealants in current urologic practice.
Optimizing Stone-free Rates With Ureteroscopy
Thanmaya G. Reddy, MD, Dean G. Assimos, MD
Ureteroscopy is being increasingly utilized in the treatment and management of patients with renal and ureteral stones. Improving stone-free rates with ureteroscopy decreases the need for ancillary procedures and improves patient outcomes and satisfaction. This article reviews contemporary literature regarding the efficacy of a wide range of currently available techniques for improving stone-free rates with this procedure.
The Obesity Epidemic and Its Impact on Urologic Care
David Mobley, MD, Neil Baum, MD
Although heart disease and cancer are the number one and two causes of death in the United States, respectively, obesity is gaining speed as a contributing cause to both of those conditions, along with diabetes, arthritis, dyslipidemia, coronary heart disease, gallbladder disease, and certain malignancies. This article reviews the root causes of obesity, the societal implications, and the implications of obesity on various urologic diseases.
Impact of the US Preventive Services Task Force Grade D Recommendation: Assessment of Evaluations for Elevated Prostate-specific Antigen and Prostate Biopsies in a Large Urology Group Practice Following Statement Revision
Kathleen F. McGinley, DO, MPH, Gregory C. McMahon, DO, Gordon A. Brown, DO, FACOS
On October 7, 2011, the United States Preventive Services Task Force released their evidence statement and grade D recommendation against prostate-specific antigen (PSA)–based prostate cancer screening. Using a time series design, the authors assessed the effect of this recommendation upon evaluations for elevated PSA levels and prostate biopsies in our large urology group practice.
From the President’s Desk: LUPGA Announces Its First CEO, Celeste Kirschner
Gary M. Kirsh, MD
Highlights From the 2015 American Urological Association Annual Meeting, May 15-19, 2015, New Orleans, LA
Best of the 2015 AUA Annual Meeting
J. Curtis Nickel, MD, FRCSC, Michael A. Gorin, MD, Alan W. Partin, MD, PhD, Dean G. Assimos, MD, Michael Brawer, MD, Heinz Nicolai, MD, Michael B. Chancellor, MD, Áine Goggins, MD, Stacy Loeb, MD, Ellen Shapiro, MD, FACS, FAAP
Retroperitoneal Ancient Schwannoma: A Case Report
Selahattin Çalişkan, MD, Gülistan Gümrükçü, MD, Cevdet Kaya, MD
The authors present a case of a retroperitoneal schwannoma that was reported to be an ancient schwannoma on pathologic evaluation.
Treatment of Colonic Injury During Percutaneous Nephrolithotomy
Hakan Öztürk, MD
The authors present a case of a 49-year-old woman who underwent left prone percutaneous nephrolithotomy that resulted in retroperitoneal colonic injury and a review of current literature.
Relationship Between Depression and Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Claire Dunphy, BA, Leanna Laor, MD, Alexis Te, MD, Steven Kaplan, MD, Bilal Chughtai, MD
The authors provide an overview of current data on the relationship between depression and lower urinary tract symptoms secondary to benign prostatic hyperplasia, with a focus on pathophysiology and patient management implications.
Penile Rehabilitation Strategies Among Prostate Cancer Survivors
Fouad Aoun, MD, MSc, Alexandre Peltier, MD, Roland van Velthoven, MD, PhD
Despite advances in technical and surgical approaches, erectile dysfunction (ED) remains the most common complication among prostate cancer survivors, adversely impacting quality of life. This article analyzes the concept and rationale of ED rehabilitation programs in prostate cancer patients. Emphasis is placed on the pathophysiology of ED after diagnosis and treatment of prostate cancer to understand the efficacy of rehabilitation programs in clinical practice.
A Review of Transplantation Practice of the Urologic Organs: Is It Only Achievable for the Kidney?
Jack Donati-Bourne, MBChB, MRCS, MSc, Harry W. Roberts, MBChB, MSc, Yaseen Rajjoub, MD, Robert A. Coleman, MBBS
Transplantation is a viable treatment option for failure of most major organs. Within urology, transplantation of the kidney and ureter are well documented; however, evidence supporting transplantation of other urologic organs is limited. Failure of these organs carries significant morbidity, and transplantation may have a role in management. This article reviews the knowledge, research, and literature surrounding transplantation of each of the urologic organs.
Diagnosis, Evaluation, and Treatment of Mixed Urinary Incontinence in Women
Bilal Chughtai, MD, Leanna Laor, MD, Claire Dunphy, BA, Richard Lee, MD, Alexis Te, MD, Steven Kaplan, MD
Mixed urinary incontinence (MUI) is a common clinical problem in the community and hospital setting. The broad definition of the term makes it difficult to diagnose, as well as determine effective treatment strategies. There are no current guidelines recommended for physicians. The estimated prevalence of this condition is approximately 30% in all women with incontinence. It has also been suggested that patients with MUI report more bothersome symptoms than either stress or urge incontinence; approximately 32% of 40- to 64-year-olds with MUI report symptoms of depression. The authors examine the diagnosis, evaluation, and treatment of patients with MUI.
From the President’s Desk: 2015 Updates and a Look Forward
Gary M. Kirsh, MD
LUGPA Welcomes Membership of Smaller Practices
Neal D. Shore, MD
Preparing for the Transition to ICD-10 by Chart Reviews of Four Urology Practice Types
Jonathan Rubenstein, MD
Juxta-adrenal Ancient Schwannoma: A Rare Retroperitoneal Tumor
Daniel A. Wollin, MD, Ganesh Sivarajan, MD, Pratibha Shukla, MD, Jonathan Melamed, MD, William C. Huang, MD, Herbert Lepor, MD
Retroperitoneal schwannoma is a rare tumor that is often misdiagnosed as malignancy due to a concerning appearance on cross-sectional imaging. Pathology and immunohistochemistry form the gold standard for diagnosis; as such, local excision is the treatment of choice for this disease. The authors present two cases of juxta-adrenal ancient schwannoma that were treated with adrenalectomy and discuss the current literature regarding this entity.
Genitourinary Presentation of Tuberculosis
Jerry Yuan, MD
Tuberculosis (TB) is less common in developed countries; however, the incidence of TB—especially resistant strains—is on the rise worldwide. Cases of TB manifesting as urologic complications are rare in the United States. Urologists should be aware of this potential manifestation, especially in patients who have recently immigrated to the United States or have traveled abroad for prolonged periods. Two cases are presented here to illustrate this entity.
Long-term Survival From Muscle-invasive Bladder Cancer With Initial Presentation of Symptomatic Cerebellar Lesion: The Role of Selective Surgical Extirpation of the Primary and Metastatic Lesion
Ganesh K. Kartha, MD, Joseph Sanfrancesco, MD, Esther Udoji, MD, Hemant Chaparala (MS4), Donna Hansel, MD, PhD, J. Stephen Jones, MD
The authors report on a case of an isolated bladder urothelial carcinoma metastasis to the cerebellum with an 11-year survival following extirpative therapy of both the primary and brain metastasis.
The Comparison of Magnetic Resonance Image–Guided Targeted Biopsy Versus Standard Template Saturation Biopsy in the Detection of Prostate Cancer
Meena Davuluri, MD, MPH, Stacy Loeb, MD
Standard and Targeted Biopsy During Follow-up for Active Surveillance
Brian Weiss, MD, Stacy Loeb, MD
MRI/Ultrasound Fusion Biopsy Versus Standard 12-Core Biopsy
Brian Weiss, MD, Stacy Loeb, MD
Relationship Between Depression and Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Claire Dunphy, BA, Leanna Laor, MD, Alexis Te, MD, Steven Kaplan, MD, Bilal Chughtai, MD
The authors provide an overview of current data on the relationship between depression and lower urinary tract symptoms secondary to benign prostatic hyperplasia, with a focus on pathophysiology and patient management implications.
Penile Rehabilitation Strategies Among Prostate Cancer Survivors
Fouad Aoun, MD, MSc, Alexandre Peltier, MD, Roland van Velthoven, MD, PhD
Despite advances in technical and surgical approaches, erectile dysfunction (ED) remains the most common complication among prostate cancer survivors, adversely impacting quality of life. This article analyzes the concept and rationale of ED rehabilitation programs in prostate cancer patients. Emphasis is placed on the pathophysiology of ED after diagnosis and treatment of prostate cancer to understand the efficacy of rehabilitation programs in clinical practice.
A Review of Transplantation Practice of the Urologic Organs: Is It Only Achievable for the Kidney?
Jack Donati-Bourne, MBChB, MRCS, MSc, Harry W. Roberts, MBChB, MSc, Yaseen Rajjoub, MD, Robert A. Coleman, MBBS
Transplantation is a viable treatment option for failure of most major organs. Within urology, transplantation of the kidney and ureter are well documented; however, evidence supporting transplantation of other urologic organs is limited. Failure of these organs carries significant morbidity, and transplantation may have a role in management. This article reviews the knowledge, research, and literature surrounding transplantation of each of the urologic organs.
Diagnosis, Evaluation, and Treatment of Mixed Urinary Incontinence in Women
Bilal Chughtai, MD, Leanna Laor, MD, Claire Dunphy, BA, Richard Lee, MD, Alexis Te, MD, Steven Kaplan, MD
Mixed urinary incontinence (MUI) is a common clinical problem in the community and hospital setting. The broad definition of the term makes it difficult to diagnose, as well as determine effective treatment strategies. There are no current guidelines recommended for physicians. The estimated prevalence of this condition is approximately 30% in all women with incontinence. It has also been suggested that patients with MUI report more bothersome symptoms than either stress or urge incontinence; approximately 32% of 40- to 64-year-olds with MUI report symptoms of depression. The authors examine the diagnosis, evaluation, and treatment of patients with MUI.
From the President’s Desk: 2015 Updates and a Look Forward
Gary M. Kirsh, MD
LUGPA Welcomes Membership of Smaller Practices
Neal D. Shore, MD
Preparing for the Transition to ICD-10 by Chart Reviews of Four Urology Practice Types
Jonathan Rubenstein, MD
Juxta-adrenal Ancient Schwannoma: A Rare Retroperitoneal Tumor
Daniel A. Wollin, MD, Ganesh Sivarajan, MD, Pratibha Shukla, MD, Jonathan Melamed, MD, William C. Huang, MD, Herbert Lepor, MD
Retroperitoneal schwannoma is a rare tumor that is often misdiagnosed as malignancy due to a concerning appearance on cross-sectional imaging. Pathology and immunohistochemistry form the gold standard for diagnosis; as such, local excision is the treatment of choice for this disease. The authors present two cases of juxta-adrenal ancient schwannoma that were treated with adrenalectomy and discuss the current literature regarding this entity.
Genitourinary Presentation of Tuberculosis
Jerry Yuan, MD
Tuberculosis (TB) is less common in developed countries; however, the incidence of TB—especially resistant strains—is on the rise worldwide. Cases of TB manifesting as urologic complications are rare in the United States. Urologists should be aware of this potential manifestation, especially in patients who have recently immigrated to the United States or have traveled abroad for prolonged periods. Two cases are presented here to illustrate this entity.
Long-term Survival From Muscle-invasive Bladder Cancer With Initial Presentation of Symptomatic Cerebellar Lesion: The Role of Selective Surgical Extirpation of the Primary and Metastatic Lesion
Ganesh K. Kartha, MD, Joseph Sanfrancesco, MD, Esther Udoji, MD, Hemant Chaparala (MS4), Donna Hansel, MD, PhD, J. Stephen Jones, MD
The authors report on a case of an isolated bladder urothelial carcinoma metastasis to the cerebellum with an 11-year survival following extirpative therapy of both the primary and brain metastasis.
The Comparison of Magnetic Resonance Image–Guided Targeted Biopsy Versus Standard Template Saturation Biopsy in the Detection of Prostate Cancer
Meena Davuluri, MD, MPH, Stacy Loeb, MD
Standard and Targeted Biopsy During Follow-up for Active Surveillance
Brian Weiss, MD, Stacy Loeb, MD